Linola Sept (Octenidine Dihydrochloride, Phenoxyethanol)

Octenidine dihydrochloride acts by binding to bacterial cell membranes, disrupting their phospholipid structure. This loss of membrane integrity leads to rapid bacterial cell death. Phenoxyethanol adds preservative and supplemental antimicrobial activity, enhancing the overall effect.

The appropriate amount of Linola Sept is determined by the prescribing clinician based on the size of the area to be treated, the type of procedure, and patient factors. No fixed dosing regimen is provided; the healthcare professional will specify the quantity to apply.

Safety data for octenidine dihydrochloride and phenoxyethanol in pregnancy or lactation are limited. Use of Linola Sept during pregnancy or while breastfeeding should only be considered if the potential benefit justifies any possible risk, and after consultation with a qualified healthcare provider.

To order Linola Sept, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with alcohol‑based antiseptics, Linola Sept’s octenidine provides a broad‑spectrum, non‑volatile antimicrobial effect with a lower risk of skin drying. Unlike povidone‑iodine, it does not stain the skin and has a rapid bactericidal action, making it suitable for repeated applications and sensitive skin.

Linola Sept should be stored at room temperature, away from direct sunlight and moisture. Keep the container tightly closed when not in use and retain it in its original packaging to protect the formulation from contamination.

Linola Sept is applied topically to clean, intact skin or wound surfaces. The clinician or caregiver spreads a thin layer of the solution using a sterile gauze or applicator, allowing it to remain in contact for the time recommended before proceeding with the procedure or dressing.

The most serious risks include severe allergic reactions such as anaphylaxis, extensive skin necrosis, and rare systemic toxicity if applied over large body areas. Immediate medical attention is required if signs of a serious reaction, such as swelling, difficulty breathing, or rapidly spreading skin damage, occur.

Linola Sept should be avoided in individuals with known hypersensitivity to octenidine dihydrochloride, phenoxyethanol, or any component of the formulation. It is also contraindicated on mucous membranes, extensive burns, or severely compromised skin without medical supervision.